Pranlukast
Top View
- Genome-Wide Association Study of Leukotriene Modifier Response In
- The Biology of Prostaglandins and Their Role As a Target for Allergic Airway Disease Therapy
- Montelukast and Churg-Strauss Syndrome R Solans, J a Bosch, a Selva, R Orriols, M Vilardell
- Role of Antileukotrienes in Acute Asthma Exacerbations
- (12) (19) STANDARD PATENT AUSTRALIAN PATENT OFFICE (11) Application No. AU 2015296210 B2
- Study Protocol of a Systematic Evidence Update by The
- (12) Patent Application Publication (10) Pub. No.: US 2016/0168090 A1 KARRA (43) Pub
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- A Double-Blind Non-Inferiority Clinical Study of Montelukast, a Cysteinyl
- Amended Clinical Trial Protocol 02
- Step 4: Stick Or Twist? a Review of Asthma Therapy
- Cayman--Eicosanoids.Pdf
- Pharmaabkommen A1 E
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years
- Customs Tariff - Schedule Xxi - 1
- The Journal of Veterinary Medical Science
- Univeristy of California, San Diego